• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    10/4/23 12:48:11 PM ET
    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Professional Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials
    Get the next $AGIL alert in real time by email

    Gainers

    Gaucho Group Holdings, Inc. (NASDAQ:VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively.

    Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares climbed 73.6% to $0.3230 after the company announced it executed strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers.

    Conduit Pharmaceuticals Inc. (NASDAQ:CDT) shares climbed 39.7% to $6.72.

    Histogen Inc. (NASDAQ:HSTO) gained 27% to $0.6350.

    Pixelworks, Inc. (NASDAQ:PXLW) gained 22% to $1.3100 after reporting preliminary revenue results for the third quarter.

    Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) shares rose 18.5% to $0.2016 after falling 15% on Tuesday. Brainstorm Cell Therapeutics recently announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS.

    BranchOut Food Inc. (NASDAQ:BOF) gained 16% to $2.0873. BranchOut pre-announced third-quarter revenue of roughly $1.1 million.

    KWESST Micro Systems Inc. (NASDAQ:KWE) climbed 13% to $1.82.

    Air Industries Group (NYSE:AIRI) gained 13% to $3.2699.

    LightPath Technologies, Inc. (NASDAQ:LPTH) climbed 11.2% to $1.59.

    Globus Maritime Limited (NASDAQ:GLBS) shares climbed 10.1% to $0.2439. Globus Maritime regained compliance with NASDAQ's minimum closing bid price.

    Star Equity Holdings, Inc. (NASDAQ:STRR) gained 9.8% to $1.0105.

    Accuray Incorporated (NASDAQ:ARAY) climbed 9.8% to $2.85. Accuray announced approval of the Tomo C radiation treatment delivery system by the Chinese National Medical Products Administration.

    CalAmp Corp. (NASDAQ:CAMP) shares jumped 9.3% to $0.4490. CalAmp is expected to release its fiscal 2024 second quarter financial results on Oct. 5, 2023.

    FLJ Group Limited (NASDAQ:FLJ) shares surged 9% to $0.2439. FLJ Group recently entered into a definitive agreement to acquire Lianlian Holdings Inc.

    LiveVox Holdings, Inc. (NASDAQ:LVOX) climbed 8.1% to $3.61 after NICE announced it will acquire the company.

    Acuity Brands, Inc. (NYSE:AYI) rose 6.6% to $178.48 following better-than-expected quarterly earnings.

    Brooge Energy Limited (NASDAQ:BROG) shares rose 6.6% to $5.85 after the company announced GULFNAV submitted a proposal to acquire all of its businesses and assets.

    RPM International Inc. (NYSE:RPM) gained 6.3% to $98.65 after the company reported better-than-expected first-quarter financial results and issued guidance.

    Losers

    Molekule Group, Inc. (NASDAQ:MKUL) dipped 30.5% to $0.1425. Molekule Group and its subsidiary have filed for Chapter 11 bankruptcy and will operate as a debtor in possession, seeking a credit facility of $5 million from dip lenders including Foundry Group Next, Armistice Capital Master Fund, SVBC, Bridge Coast Capital.

    A10 Networks, Inc. (NYSE:ATEN) fell 29.7% to $10.66 after the company reported preliminary third-quarter financial results. The company sees quarterly revenue of $56.5 million-$58.5 million, vs. consensus of $74.65 million.

    Inhibikase Therapeutics, Inc. (NASDAQ:IKT) declined 26.4% to $1.0299. Inhibikase Therapeutics received FDA orphan drug designation for risvodetinib for the treatment of multiple system atrophy.

    Kineta, Inc. (NASDAQ:KA) shares fell 26.6% to $2.90 after the company announced a $3 million registered direct offering priced at-the-market under Nasdaq rules.

    Beneficient (NASDAQ:BENF) fell 23.8% to $1.92.

    Trinseo PLC (NYSE:TSE) dipped 21.5% to $6.51. Jefferies downgraded Trinseo from Buy to Hold and lowered the price target from $22 to $9.

    Profire Energy, Inc. (NASDAQ:PFIE) fell 19.9% to $2.16.

    MSP Recovery, Inc. (NASDAQ:LIFW) fell 17.4% to $0.2066 trading after the company announced a 1-for-25 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.

    VIQ Solutions Inc. (NASDAQ:VQS) fell 16.6% to $0.1390 after gaining 27% on Tuesday. Last Wednesday, VIQ Solutions announced the delisting of its stock from the Nasdaq and the resignation of its director.

    The Dixie Group, Inc. (NASDAQ:DXYN) dipped 16.4% to $0.6011.

    Amprius Technologies, Inc. (NYSE:AMPX) fell 16.3% to $4.21.

    ALX Oncology Holdings Inc. (NASDAQ:ALXO) declined 16.2% to $6.30. Cantor Fitzgerald maintained ALX Oncology Holdings with an Overweight and raised the price target from $18 to $23.

    Ocean Biomedical, Inc. (NASDAQ:OCEA) fell 15% to $2.3205.

    bioAffinity Technologies, Inc. (NASDAQ:BIAF) fell 12.4% to $1.13. Biofrontera announced preliminary third-quarter revenues of $8.7 million to $9 million.

    AgileThought, Inc. (NASDAQ:AGIL) shares fell 11.7% to $0.1501 after gaining over 6% on Tuesday.

    Allego N.V. (NYSE:ALLG) fell 11% to $2.2669.

    B&G Foods, Inc (NYSE:BGS) shares declined 10.8% to $8.45. Piper Sandler downgraded B&G Foods from Neutral to Underweight and lowered the price target from $14 to $8.

    IGM Biosciences, Inc. (NASDAQ:IGMS) fell 10.5% to $6.01. IGM Biosciences announced retirement of Chairman Michael Loberg effective Oct. 3.

    Trinity Industries, Inc. (NYSE:TRN) tumbled 9.8% to $21.04. Trinity Industries reported deliveries of 4,325 new railcars in the third quarter, 685 units below its projection due to closing of US-Mexico border.

    Femasys Inc. (NASDAQ:FEMY) fell 9.3% to $2.2587 after dipping 36% on Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September.

    Kronos Worldwide, Inc. (NYSE:KRO) declined 9.1% to $6.69. Barclays maintained Kronos Worldwide with an Underweight and lowered the price target from $7 to $6.

    Helen of Troy Limited (NASDAQ:HELE) fell 8.6% to $103.84 after the company reported second-quarter financial results and issued guidance.

    Cal-Maine Foods, Inc. (NASDAQ:CALM) fell 7.6% to $43.90 after the company posted weaker-than-expected sales for its first quarter on Tuesday.

    GSE Systems, Inc. (NASDAQ:GVP) fell 7.4% to $0.1916.

    Novartis AG (NYSE:NVS) shares fell 4.2% to $95.28. Novartis announced it completed the spin-off of Sandoz unit.

    Now Read This: Top 5 Health Care Stocks That May Plunge In October

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $AIRI
    $ALLG
    $ALXO

    CompanyDatePrice TargetRatingAnalyst
    ALX Oncology Holdings Inc.
    $ALXO
    3/19/2026$5.00Overweight
    Wells Fargo
    Novartis AG
    $NVS
    3/11/2026$180.00Hold → Buy
    Argus
    ALX Oncology Holdings Inc.
    $ALXO
    3/6/2026$6.00Buy
    UBS
    Inhibikase Therapeutics Inc.
    $IKT
    3/4/2026$4.00Buy
    Ladenburg Thalmann
    RPM International Inc.
    $RPM
    3/4/2026$125.00Neutral → Outperform
    Robert W. Baird
    Amprius Technologies Inc.
    $AMPX
    2/23/2026$17.00Buy
    Craig Hallum
    LightPath Technologies Inc.
    $LPTH
    1/29/2026$15.00Buy
    Canaccord Genuity
    Amprius Technologies Inc.
    $AMPX
    1/29/2026$20.00Buy
    Needham
    More analyst ratings

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    SEC Filings

    View All

    ALX Oncology Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)

    4/13/26 8:35:12 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Beneficient

    424B3 - Beneficient (0001775734) (Filer)

    4/10/26 7:47:58 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    SEC Form DEFA14A filed by Beneficient

    DEFA14A - Beneficient (0001775734) (Filer)

    4/10/26 7:44:32 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on ALX Oncology with a new price target

    Wells Fargo initiated coverage of ALX Oncology with a rating of Overweight and set a new price target of $5.00

    3/19/26 8:25:33 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Novartis AG upgraded by Argus with a new price target

    Argus upgraded Novartis AG from Hold to Buy and set a new price target of $180.00

    3/11/26 8:29:46 AM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UBS resumed coverage on ALX Oncology with a new price target

    UBS resumed coverage of ALX Oncology with a rating of Buy and set a new price target of $6.00

    3/6/26 8:38:03 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Porcelain Michael

    4 - AIR INDUSTRIES GROUP (0001009891) (Issuer)

    4/13/26 4:17:13 PM ET
    $AIRI
    Military/Government/Technical
    Industrials

    SEC Form 3 filed by new insider V-Co Investors 3 Llc

    3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)

    4/10/26 4:54:28 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Miele Paul Michael

    3 - ACCURAY INC (0001138723) (Issuer)

    4/10/26 4:40:03 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mayer Steven F bought $30,878 worth of shares (54,875 units at $0.56), increasing direct ownership by 4% to 1,545,620 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/23/26 4:10:08 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    Director Mayer Steven F bought $103,797 worth of shares (195,125 units at $0.53), increasing direct ownership by 15% to 1,490,745 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/20/26 4:10:06 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

    - Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (("ALX Oncology, NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced the appointment of Jeff Knight, M.P.H., as Chief Development and Operating Officer, effective April 13, 2026. "Jeff is a highly accomplished leader with deep expertise across clinical development and operations, and a strong track record of both advancing innovative thera

    4/13/26 8:30:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Closes $8.75 Million GP Primary Capital Transaction

    DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of an $8.75 million primary capital commitment in Quartus AI Fund LP ("Fund"), a fund managed by Quartus Capital Partners LLC ("Quartus"), a New York based investment firm investing in growth stage AI and technology ventures. Quartus is led by AI pioneers, technologists, and seasoned operators (the "Transaction"). The Transaction continues the Company's efforts to deliver primary capital

    4/10/26 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    A10 Networks to Announce First Quarter 2026 Financial Results on April 28, 2026

    A10 Networks (NYSE:ATEN), a leading provider of secure application services and solutions, today announced that the company's first quarter 2026 financial results will be released after the markets close on Tuesday, April 28, 2026. Management will host a call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results. Interested parties may access the conference call by dialing (888) 506-0062 (toll-free) or (973) 528-0011 (international) and referencing access code: 360454. A live audio webcast of the conference call will be accessible from the "Investor Relations" section of A10 Network's website at investors.a10networks.com. The webcast will be archived for one

    4/9/26 8:00:00 AM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 1, 2024 - FDA Roundup: November 1, 2024

    For Immediate Release: November 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub,” by Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER) and Peter Marks, M.D., Ph.D., director

    11/1/24 3:18:19 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Trinseo PLC

    SC 13G - Trinseo PLC (0001519061) (Subject)

    12/17/24 5:11:10 PM ET
    $TSE
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Leadership Updates

    Live Leadership Updates

    View All

    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

    - Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (("ALX Oncology, NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced the appointment of Jeff Knight, M.P.H., as Chief Development and Operating Officer, effective April 13, 2026. "Jeff is a highly accomplished leader with deep expertise across clinical development and operations, and a strong track record of both advancing innovative thera

    4/13/26 8:30:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LightPath Appoints Two Senior Sales Executives to Drive Defense and Commercial Growth

    Seasoned Defense and Aerospace Executives to Drive Revenue Growth and Expand Market Reach Across LightPath's Defense and Commercial PlatformsORLANDO, Fla., April 8, 2026 /PRNewswire/ -- LightPath Technologies, Inc. (NASDAQ:LPTH) ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced the appointments of Doug Schoen as Senior Vice President of Global Sales and Ryan Workman as Vice President, Business Development & Product Management, effective April 6, 2026. Both executives bring extensive defense industry leadership experience and will play key roles in accelerating the Compan

    4/8/26 8:31:00 AM ET
    $LPTH
    Semiconductors
    Technology

    Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

    MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. Miele will join Accuray's executive leadership team and lead the company's global commercial organization as Accuray continues to advance its transformation and strengthen execution across its portfolio. "Paul brings deep global commercial leadership experience and a strong track record of driving transform

    4/6/26 9:00:00 AM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $AGIL
    $AIRI
    $ALLG
    $ALXO
    Financials

    Live finance-specific insights

    View All

    A10 Networks to Announce First Quarter 2026 Financial Results on April 28, 2026

    A10 Networks (NYSE:ATEN), a leading provider of secure application services and solutions, today announced that the company's first quarter 2026 financial results will be released after the markets close on Tuesday, April 28, 2026. Management will host a call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results. Interested parties may access the conference call by dialing (888) 506-0062 (toll-free) or (973) 528-0011 (international) and referencing access code: 360454. A live audio webcast of the conference call will be accessible from the "Investor Relations" section of A10 Network's website at investors.a10networks.com. The webcast will be archived for one

    4/9/26 8:00:00 AM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    Trinity Industries, Inc. Announces Date for Earnings Release

    Trinity Industries, Inc. (NYSE:TRN) ("Trinity") announced today that it will report its financial results for the three months ended March 31, 2026 before the financial markets open on April 30, 2026. Trinity will conduct a conference call shortly thereafter at 8:00 a.m. Eastern on April 30, 2026 to discuss its results. Investors may listen to the conference call via the following live and replay methods: Webcast: To listen to the fourth quarter earnings conference call via webcast, visit the Investor Relations section of the Company's website at www.trin.net and access the Events and Presentations webpage. A replay of the webcast will be available on the Company's website for one yea

    4/8/26 6:55:00 AM ET
    $TRN
    Railroads
    Industrials

    RPM Reports Record Fiscal 2026 Third-Quarter Results

    Record third-quarter sales of $1.61 billion, an increase of 8.9% compared to the prior-year Third-quarter net income of $51.4 million, diluted EPS of $0.40, and EBIT of $84.1 million Record third-quarter adjusted diluted EPS of $0.57, an increase of 62.9% compared to the prior-year and record adjusted EBIT of $116.4 million, an increase of 48.8% compared to the prior-year Reaffirming fiscal 2026 fourth-quarter sales guidance of mid-single-digit sales growth and low- to high-single digit adjusted EBIT growth RPM International Inc. (NYSE:RPM), a world leader in specialty coatings, sealants and building materials, today reported financial results for its fiscal 2026 third quarter

    4/8/26 6:45:00 AM ET
    $RPM
    Paints/Coatings
    Consumer Discretionary